Auspex bumps share number for IPO

Rare neurology disease play Auspex Pharmaceuticals Inc. (La Jolla, Calif.) bumped to 6 million from 5.5 million the number of shares it plans to sell at $10-$12 in an IPO on NASDAQ. At the $11 midpoint and bumped-up share figure, the company would raise $66 million and be valued at $236.8 million. Auspex filed to raise up to $69 million in the IPO in December. Stifel; BMO Capital Markets; Baird; William Blair; and Ladenburg Thalmann are underwriters (see BioCentury Extra, Jan. 17). ...